ISSN 1977-091X

Official Journal

of the European Union

C 34
European flag  

English edition

Information and Notices

Volume 62
28 January 2019

Contents

page

 

II   Information

 

INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

 

European Commission

2019/C 34/01

Non-opposition to a notified concentration (Case M.9017 — SK Capital Partners/Schenectady International Group) ( 1 )

1

2019/C 34/02

Non-opposition to a notified concentration (Case M.9214 — MUFG HD/Akamai/JV) ( 1 )

1

 

IV   Notices

 

NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

 

European Commission

2019/C 34/03

Euro exchange rates

2

2019/C 34/04

Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) (Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006)  ( 1 )

3

 

NOTICES FROM MEMBER STATES

2019/C 34/05

Update of the list of residence permits referred to in Article 2(16) of Regulation (EU) 2016/399 of the European Parliament and of the Council on a Union Code on the rules governing the movement of persons across borders (Schengen Borders Code)

4

 

 

(1)   Text with EEA relevance.

EN

 

II Information

INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

28.1.2019   

EN

Official Journal of the European Union

C 34/1

Non-opposition to a notified concentration

(Case M.9017 — SK Capital Partners/Schenectady International Group)

(Text with EEA relevance)

(2019/C 34/01)

On 11 October 2018, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32018M9017. EUR-Lex is the online access to European law.

(1)  OJ L 24, 29.1.2004, p. 1.

28.1.2019   

EN

Official Journal of the European Union

C 34/1

Non-opposition to a notified concentration

(Case M.9214 — MUFG HD/Akamai/JV)

(Text with EEA relevance)

(2019/C 34/02)

On 17 January 2019, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32019M9214. EUR-Lex is the online access to European law.

(1)  OJ L 24, 29.1.2004, p. 1.

IV Notices

NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

28.1.2019   

EN

Official Journal of the European Union

C 34/2

Euro exchange rates (1)

25 January 2019

(2019/C 34/03)

1 euro =


 

Currency

Exchange rate

USD

US dollar

1,1346

JPY

Japanese yen

124,72

DKK

Danish krone

7,4664

GBP

Pound sterling

0,86580

SEK

Swedish krona

10,2980

CHF

Swiss franc

1,1310

ISK

Iceland króna

135,90

NOK

Norwegian krone

9,7045

BGN

Bulgarian lev

1,9558

CZK

Czech koruna

25,697

HUF

Hungarian forint

318,26

PLN

Polish zloty

4,2910

RON

Romanian leu

4,7688

TRY

Turkish lira

5,9806

AUD

Australian dollar

1,5939

CAD

Canadian dollar

1,5107

HKD

Hong Kong dollar

8,9021

NZD

New Zealand dollar

1,6720

SGD

Singapore dollar

1,5392

KRW

South Korean won

1 270,87

ZAR

South African rand

15,4900

CNY

Chinese yuan renminbi

7,6699

HRK

Croatian kuna

7,4315

IDR

Indonesian rupiah

15 980,84

MYR

Malaysian ringgit

4,6888

PHP

Philippine peso

59,662

RUB

Russian rouble

75,0193

THB

Thai baht

35,876

BRL

Brazilian real

4,2737

MXN

Mexican peso

21,4546

INR

Indian rupee

80,6340

(1)  Source: reference exchange rate published by the ECB.

28.1.2019   

EN

Official Journal of the European Union

C 34/3

Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)

(Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006 (1) )

(Text with EEA relevance)

(2019/C 34/04)

Decisions granting an authorisation

Reference of the decision (2)

Date of decision

Substance name

Holder of the authorisation

Authorisation number

Authorised use

Date of expiry of review period

Reasons for the decision

C(2019) 169

21 January 2019

1,2-dichloroethane

EC No 203-458-1

CAS No 107-06-2

ORGAPHARM, Rue du Moulin de la canne, 45300 Pithiviers, France.

REACH/19/11/0

Use of 1,2-dichloroethane as process solvent in the manufacture of an Active Pharmaceutical Ingredient: Flecainide acetate.

22 November 2024

In accordance with Article 60(4) of Regulation (EC) No 1907/2006, the socioeconomic benefits outweigh the risk to human health arising from the use of the substance and there are no suitable alternative substances or technologies in terms of their technical and economic feasibility.

REACH/19/11/1

Use of 1,2-dichloroethane as process solvent in the manufacture of an Active Pharmaceutical Ingredient: Nefopam hydrochloride

(1)  OJ L 396, 30.12.2006, p. 1.

(2)  The decision is available on the European Commission website at: http://ec.europa.eu/growth/sectors/chemicals/reach/about/index_en.htm

NOTICES FROM MEMBER STATES

28.1.2019   

EN

Official Journal of the European Union

C 34/4

Update of the list of residence permits referred to in Article 2(16) of Regulation (EU) 2016/399 of the European Parliament and of the Council on a Union Code on the rules governing the movement of persons across borders (Schengen Borders Code) (1)

(2019/C 34/05)

The publication of the list of residence permits referred to in Article 2(16) of Regulation (EU) 2016/399 of the European Parliament and of the Council of 9 March 2016 on a Union Code on the rules governing the movement of persons across borders (Schengen Borders Code) (2) is based on the information communicated by the Member States to the Commission in conformity with Article 39 of the Schengen Borders Code.

In addition to publication in the OJ, a monthly update is available on the website of the Directorate-General for Migration and Home Affairs.

ITALY

Replacement of the list published in OJ C 200, 28.6.2014.

LIST OF RESIDENCE PERMITS ISSUED BY MEMBER STATES

1.

Residence permits issued using the uniform format, as laid down in Regulation (EC) No 1030/2002, as amended:

—

Permessi di soggiorno con validità da tre mesi a un massimo di cinque anni, recanti l'indicazione dello specifico motivo del soggiorno;

(Residence permits valid for between three months and five years, indicating the specific reason for stay);

—

Permessi di soggiorno con validità permanente:

(Permanent residence permits):

—

Permesso di soggiorno Ue per soggiornanti di lungo periodo

(Long-term residents' EU residence permit)

(pursuant to Directive 2003/109/EC);

—

Permesso di soggiorno Ue per lungo soggiornanti ‘ex titolare Carta blu

(Ue’ Long-term residents' EU residence permit ‘Former EU Blue Card) holder’ (pursuant to Directive 2009/50/EC)

2.

Residence permits issued in paper form:

—

Permessi di soggiorno con validità massima di tre mesi, rilasciati per uno dei seguenti motivi:

—

Gara sportiva;

—

Missione;

(Residence permits valid for up to three months issued for one of the following reasons:

—

Sporting event;

—

Mission);

—

Carta di soggiorno con validità permanente

(Permanent residence card):

(issued pursuant to Directive 2003/109/EC for long-term residents, equivalent to a long-term residents' EC residence permit);

—

Carta di soggiorno per familiari di cittadini dell'UE, con validità fino a cinque anni oppure permanente

(Residence card for family members of EU citizens, valid for up to five years or permanently) (pursuant to Directive 2004/38/EC);

On 15 October 2013, Italy adopted a new residence permit in paper form to replace the one in use.

—

Carta di soggiorno di familiare di un cittadino dell'Unione, adottato a partire dal 23 marzo 2015, rilasciato in attuazione della Direttiva 2004/38/CE.

(Residence card of a family member of a Union citizen, adopted with effect from 23 March 2015, issued pursuant to Directive 2004/38/EC).

Residence permits issued before the new models come into force shall remain valid until they expire or are replaced.

List of previous publications

 

OJ C 247, 13.10.2006, p. 1.

 

OJ C 153, 6.7.2007, p. 5.

 

OJ C 192, 18.8.2007, p. 11.

 

OJ C 271, 14.11.2007, p. 14.

 

OJ C 57, 1.3.2008, p. 31.

 

OJ C 134, 31.5.2008, p. 14.

 

OJ C 207, 14.8.2008, p. 12.

 

OJ C 331, 21.12.2008, p. 13.

 

OJ C 3, 8.1.2009, p. 5.

 

OJ C 64, 19.3.2009, p. 15.

 

OJ C 198, 22.8.2009, p. 9.

 

OJ C 239, 6.10.2009, p. 2.

 

OJ C 298, 8.12.2009, p. 15.

 

OJ C 308, 18.12.2009, p. 20.

 

OJ C 35, 12.2.2010, p. 5.

 

OJ C 82, 30.3.2010, p. 26.

 

OJ C 103, 22.4.2010, p. 8.

 

OJ C 108, 7.4.2011, p. 6.

 

OJ C 157, 27.5.2011, p. 5.

 

OJ C 201, 8.7.2011, p. 1.

 

OJ C 216, 22.7.2011, p. 26.

 

OJ C 283, 27.9.2011, p. 7.

 

OJ C 199, 7.7.2012, p. 5.

 

OJ C 214, 20.7.2012, p. 7.

 

OJ C 298, 4.10.2012, p. 4.

 

OJ C 51, 22.2.2013, p. 6.

 

OJ C 75, 14.3.2013, p. 8.

 

OJ C 77, 15.3.2014, p. 4.

 

OJ C 118, 17.4.2014, p. 9.

 

OJ C 200, 28.6.2014, p. 59.

 

OJ C 304, 9.9.2014, p. 3.

 

OJ C 390, 5.11.2014, p. 12.

 

OJ C 210, 26.6.2015, p. 5.

 

OJ C 286, 29.8.2015, p. 3.

 

OJ C 151, 28.4.2016, p. 4.

 

OJ C 16, 18.1.2017, p. 5.

 

OJ C 69, 4.3.2017, p. 6.

 

OJ C 94, 25.3.2017, p. 3.

 

OJ C 297, 8.9.2017, p. 3.

 

OJ C 343, 13.10.2017, p. 12.

 

OJ C 100, 16.3.2018, p. 25.

 

OJ C 144, 25.4.2018, p. 8.

 

OJ C 173, 22.5.2018, p. 6.

 

OJ C 222, 26.6.2018, p. 12.

 

OJ C 248, 16.7.2018, p. 4.

 

OJ C 269, 31.7.2018, p. 27.

 

OJ C 345, 27.9.2018, p. 5.

(1)  See the list of previous publications at the end of this update.

(2)  OJ L 77, 23.3.2016, p. 1.